Trading Of Pharmaceutical Companies in Malaysia

The Malaysian government has been actively encouraging the development of the country’s pharmaceutical industry, with the goal of making Malaysia a regional hub for the manufacture and export of pharmaceutical products. As part of this effort, the government has implemented a number of policies and initiatives to attract foreign investment and encourage the growth of domestic companies.

One of the most significant policy changes has been the introduction of the “Malaysia My Second Home” program, which offers a ten-year residency visa to foreign nationals who invest a minimum of RM500,000 (approximately US$120,000) in the country. This program has been particularly successful in attracting retirees and investors from other Southeast Asian countries.

Another key policy change has been the streamlining of the approval process for new drugs and medical devices. Previously, the approval process was lengthy and often unpredictable, leading many companies to avoid Malaysia altogether. However, the government has worked to streamline the process and reduce the time it takes to bring new products to market.

As a result of these and other initiatives, the Malaysian pharmaceutical industry has experienced strong growth in recent years. The value of pharmaceutical exports has nearly tripled since 2010, reaching RM16.4 billion (approximately US$4 billion) in